United States Point of Care (PoC) Molecular Diagnostics Market Report 2017

Name: United States Point of Care (PoC) Molecular Diagnostics Market Report 2017
Brand: QYResearch
SKU: U0822370624EN
Price: 3800 USD
Availability: InStock

December 2017 | 98 pages | ID: U0822370624EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Point of Care (PoC) Molecular Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Point of Care (PoC) Molecular Diagnostics in these regions, from 2012 to 2022 (forecast).

United States Point of Care (PoC) Molecular Diagnostics market competition by top manufacturers/players, with Point of Care (PoC) Molecular Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals
Diagnostic Laboratories
Research & Academic Laboratories

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Point of Care (PoC) Molecular Diagnostics Market Report 2017

1 POINT OF CARE (POC) MOLECULAR DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Point of Care (PoC) Molecular Diagnostics
1.2 Classification of Point of Care (PoC) Molecular Diagnostics by Product Category
  1.2.1 United States Point of Care (PoC) Molecular Diagnostics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Point of Care (PoC) Molecular Diagnostics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Polymerase Chain Reaction (Real Time PCR)
  1.2.4 In Situ Hybridization
  1.2.5 Chips and Microarrays
  1.2.6 Mass Spectrometry
  1.2.7 Sequencing
  1.2.8 Isothermal Amplification
  1.2.9 Others
1.3 United States Point of Care (PoC) Molecular Diagnostics Market by Application/End Users
  1.3.1 United States Point of Care (PoC) Molecular Diagnostics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Diagnostic Laboratories
  1.3.4 Research & Academic Laboratories
1.4 United States Point of Care (PoC) Molecular Diagnostics Market by Region
  1.4.1 United States Point of Care (PoC) Molecular Diagnostics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
  1.4.3 Southwest Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
  1.4.5 New England Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
  1.4.6 The South Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
  1.4.7 The Midwest Point of Care (PoC) Molecular Diagnostics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Point of Care (PoC) Molecular Diagnostics (2012-2022)
  1.5.1 United States Point of Care (PoC) Molecular Diagnostics Sales and Growth Rate (2012-2022)
  1.5.2 United States Point of Care (PoC) Molecular Diagnostics Revenue and Growth Rate (2012-2022)

2 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Point of Care (PoC) Molecular Diagnostics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Point of Care (PoC) Molecular Diagnostics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Point of Care (PoC) Molecular Diagnostics Average Price by Players/Suppliers (2012-2017)
2.4 United States Point of Care (PoC) Molecular Diagnostics Market Competitive Situation and Trends
  2.4.1 United States Point of Care (PoC) Molecular Diagnostics Market Concentration Rate
  2.4.2 United States Point of Care (PoC) Molecular Diagnostics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Point of Care (PoC) Molecular Diagnostics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Point of Care (PoC) Molecular Diagnostics Sales and Market Share by Region (2012-2017)
3.2 United States Point of Care (PoC) Molecular Diagnostics Revenue and Market Share by Region (2012-2017)
3.3 United States Point of Care (PoC) Molecular Diagnostics Price by Region (2012-2017)

4 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Point of Care (PoC) Molecular Diagnostics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Point of Care (PoC) Molecular Diagnostics Revenue and Market Share by Type (2012-2017)
4.3 United States Point of Care (PoC) Molecular Diagnostics Price by Type (2012-2017)
4.4 United States Point of Care (PoC) Molecular Diagnostics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Point of Care (PoC) Molecular Diagnostics Sales and Market Share by Application (2012-2017)
5.2 United States Point of Care (PoC) Molecular Diagnostics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Corporation Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche Diagnostics
  6.2.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sysmex Corporation
  6.3.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abaxis
  6.4.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abaxis Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BioMerieux SA
  6.6.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BioMerieux SA Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Rad Laboratories
  6.7.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Danaher Corporation
  6.8.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Danaher Corporation Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 OraSure Technologies
  6.9.2 Point of Care (PoC) Molecular Diagnostics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 OraSure Technologies Point of Care (PoC) Molecular Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 POINT OF CARE (POC) MOLECULAR DIAGNOSTICS MANUFACTURING COST ANALYSIS

7.1 Point of Care (PoC) Molecular Diagnostics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Point of Care (PoC) Molecular Diagnostics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Point of Care (PoC) Molecular Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Point of Care (PoC) Molecular Diagnostics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES POINT OF CARE (POC) MOLECULAR DIAGNOSTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Point of Care (PoC) Molecular Diagnostics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Point of Care (PoC) Molecular Diagnostics Sales Volume Forecast by Type (2017-2022)
11.3 United States Point of Care (PoC) Molecular Diagnostics Sales Volume Forecast by Application (2017-2022)
11.4 United States Point of Care (PoC) Molecular Diagnostics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Point of Care (PoC) Molecular Diagnostics
Figure United States Point of Care (PoC) Molecular Diagnostics Market Size (K Units) by Type (2012-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume Market Share by Type (Product Category) in 2016
Figure Polymerase Chain Reaction (Real Time PCR) Product Picture
Figure In Situ Hybridization Product Picture
Figure Chips and Microarrays Product Picture
Figure Mass Spectrometry Product Picture
Figure Sequencing Product Picture
Figure Isothermal Amplification Product Picture
Figure Others Product Picture
Figure United States Point of Care (PoC) Molecular Diagnostics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Point of Care (PoC) Molecular Diagnostics by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostic Laboratories Examples
Table Key Downstream Customer in Diagnostic Laboratories
Figure Research & Academic Laboratories Examples
Table Key Downstream Customer in Research & Academic Laboratories
Figure United States Point of Care (PoC) Molecular Diagnostics Market Size (Million USD) by Region (2012-2022)
Figure The West Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Point of Care (PoC) Molecular Diagnostics Sales Share by Players/Suppliers
Figure 2017 United States Point of Care (PoC) Molecular Diagnostics Sales Share by Players/Suppliers
Figure United States Point of Care (PoC) Molecular Diagnostics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Point of Care (PoC) Molecular Diagnostics Revenue Share by Players/Suppliers
Figure 2017 United States Point of Care (PoC) Molecular Diagnostics Revenue Share by Players/Suppliers
Table United States Market Point of Care (PoC) Molecular Diagnostics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Point of Care (PoC) Molecular Diagnostics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Point of Care (PoC) Molecular Diagnostics Market Share of Top 3 Players/Suppliers
Figure United States Point of Care (PoC) Molecular Diagnostics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Point of Care (PoC) Molecular Diagnostics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Point of Care (PoC) Molecular Diagnostics Product Category
Table United States Point of Care (PoC) Molecular Diagnostics Sales (K Units) by Region (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Share by Region (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Share by Region (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Market Share by Region in 2016
Table United States Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Revenue Share by Region (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Revenue Market Share by Region (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Revenue Market Share by Region in 2016
Table United States Point of Care (PoC) Molecular Diagnostics Price (USD/Unit) by Region (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales (K Units) by Type (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Share by Type (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Share by Type (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Market Share by Type in 2016
Table United States Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Point of Care (PoC) Molecular Diagnostics by Type (2012-2017)
Figure Revenue Market Share of Point of Care (PoC) Molecular Diagnostics by Type in 2016
Table United States Point of Care (PoC) Molecular Diagnostics Price (USD/Unit) by Types (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Growth Rate by Type (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales (K Units) by Application (2012-2017)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Market Share by Application in 2016
Table United States Point of Care (PoC) Molecular Diagnostics Sales Growth Rate by Application (2012-2017)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Growth Rate by Application (2012-2017)
Table Bayer Corporation Basic Information List
Table Bayer Corporation Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Corporation Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Bayer Corporation Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Bayer Corporation Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Sysmex Corporation Basic Information List
Table Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Abaxis Basic Information List
Table Abaxis Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abaxis Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Abaxis Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Abaxis Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table BioMerieux SA Basic Information List
Table BioMerieux SA Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioMerieux SA Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure BioMerieux SA Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure BioMerieux SA Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Danaher Corporation Basic Information List
Table Danaher Corporation Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher Corporation Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure Danaher Corporation Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure Danaher Corporation Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table OraSure Technologies Basic Information List
Table OraSure Technologies Point of Care (PoC) Molecular Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure OraSure Technologies Point of Care (PoC) Molecular Diagnostics Sales Growth Rate (2012-2017)
Figure OraSure Technologies Point of Care (PoC) Molecular Diagnostics Sales Market Share in United States (2012-2017)
Figure OraSure Technologies Point of Care (PoC) Molecular Diagnostics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Point of Care (PoC) Molecular Diagnostics
Figure Manufacturing Process Analysis of Point of Care (PoC) Molecular Diagnostics
Figure Point of Care (PoC) Molecular Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Point of Care (PoC) Molecular Diagnostics Major Players/Suppliers in 2016
Table Major Buyers of Point of Care (PoC) Molecular Diagnostics
Table Distributors/Traders List
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Type in 2022
Table United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Application in 2022
Table United States Point of Care (PoC) Molecular Diagnostics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Point of Care (PoC) Molecular Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Point of Care (PoC) Molecular Diagnostics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Point of Care (PoC) Molecular Diagnostics Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports